Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeholdingselskabet SD Dental Healthcare ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 1.5% 2.0%   Bankruptcy risk   7.6% 13.2% 9.7% 4.3% 6.1% 5.4% 18.9% 14.8%   Credit score (0-100)   33 18 25 46 37 41 7 14   Credit rating   BB BB BB BBB BBB BBB B BB   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,303 -131 904 -43.3 -33.4 -35.6 0.0 0.0   EBITDA   784 -282 784 -44.9 -33.4 -35.6 0.0 0.0   EBIT   630 -282 784 -44.9 -33.4 -35.6 0.0 0.0   Pre-tax profit (PTP)   471.2 -218.1 1,152.3 278.2 42.3 84.2 0.0 0.0   Net earnings   342.1 -155.3 984.6 288.1 52.0 92.1 0.0 0.0   Pre-tax profit without non-rec. items   471 -218 1,152 278 42.3 84.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   530 130 130 130 130 130 0.0 0.0   Shareholders equity total   -946 -1,101 -116 172 224 316 266 266   Interest-bearing liabilities   1,078 619 581 835 491 519 0.0 0.0   Balance sheet total (assets)   916 569 939 1,273 748 868 266 266   Net Debt   1,033 588 571 834 481 517 -266 -266     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,303 -131 904 -43.3 -33.4 -35.6 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 0.0% 22.8% -6.5% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   916 569 939 1,273 748 868 266 266   Balance sheet change%   0.0% -37.8% 64.9% 35.6% -41.3% 16.1% -69.4% 0.0%   Added value   783.8 -281.9 784.3 -44.9 -33.4 -35.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   376 -400 0 0 0 0 -130 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   48.4% 216.0% 86.7% 103.7% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.6% -12.2% 86.2% 24.3% 5.7% 10.5% 0.0% 0.0%   ROI %   44.7% -24.1% 191.5% 35.1% 6.6% 10.9% 0.0% 0.0%   ROE %   37.4% -20.9% 130.6% 51.9% 26.3% 34.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -50.8% -65.9% -11.0% 13.5% 29.9% 36.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   131.8% -208.7% 72.8% -1,859.6% -1,442.0% -1,454.6% 0.0% 0.0%   Gearing %   -113.9% -56.2% -499.2% 486.8% 219.6% 164.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.0% 0.4% 3.7% 0.6% 2.2% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Cash and cash equivalent   44.5 31.0 10.2 1.0 9.7 1.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,743.8 -1,629.2 -1,030.0 -1,079.0 -509.9 -537.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   784 -282 784 -45 -33 -36 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   784 -282 784 -45 -33 -36 0 0   EBIT / employee   630 -282 784 -45 -33 -36 0 0   Net earnings / employee   342 -155 985 288 52 92 0 0